Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 12:51 PM
Ignite Modification Date:
2025-12-25 @ 12:16 PM
NCT ID:
NCT00456261
Group ID:
EG001
Title:
Bevacizumab/Pemetrexed/Carboplatin
Description:
Cohort B, will receive bevacizumab 15mg/kg by vein over 30-90 minutes followed by pemetrexed 500 mg/m2 by vein over approximately 10 minutes followed by carboplatin AUC=5 by vein over 30-60 minutes. This regimen will be given on day 1 of each treatment cycle. Each cycle is 21 days long. As long as their disease does not worsen patients can receive up to a maximum of 6 cycles of this combination chemotherapy. Following that they can receive bevacizumab alone once every 3 weeks as long as their disease does not worsen.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
21
Serious Number At Risk:
55
Other Number Affected:
55
Other Number At Risk:
55
Study:
NCT00456261
Results Section:
NCT00456261
Adverse Events Module:
NCT00456261